Seraxis is a pioneering brand working towards finding a cure for type 1 diabetes. Their focus lies in developing a revolutionary cell therapy to treat insulin-dependent diabetes. By harnessing breakthroughs in regenerative medicine, Seraxis aims to provide a long-term normalization of blood glucose levels without the need for immuno-suppressants.

Key to their cell replacement therapy, SR-01, is the utilization of lab-grown human islets that are as potent as those found in a healthy pancreas. What sets Seraxis apart is their innovative technology that allows for the implantation of a therapeutic dose of replacement islets, all while avoiding the requirement for immune suppression. These two vital components have been developed and manufactured in a clinically acceptable manner, making them practical and accessible for the millions of patients in need.

With a goal-driven approach, the Seraxis team of scientific and medical experts have developed novel cell and encapsulation technologies to make their vision a reality. If you're interested in learning more or getting in touch, visit their website or contact them directly through the provided details